Faron Pharmaceuticals Oy

FARN.L · LSE
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-£10-£12-£14-£17
Dep. & Amort.£0£0£0£0
Deferred Tax£0£0£0£0
Stock-Based Comp.£0£0£0£2
Change in WC£0£2-£3-£1
Other Non-Cash£4-£5£12£10
Operating Cash Flow-£5-£14-£9-£11
Investing Activities
PP&E Inv.£0£0£0£0
Net Acquisitions£0£0£0£0
Inv. Purchases£0£0£0£0
Inv. Sales/Matur.£0£0£0£0
Other Inv. Act.-£0-£0-£0-£0
Investing Cash Flow-£0-£0-£0-£0
Financing Activities
Debt Repay.£0£0£0£0
Stock Issued£0£0£0£0
Stock Repurch.£0-£4£0£0
Dividends Paid£0£0£0£0
Other Fin. Act.£7-£2£32£6
Financing Cash Flow£7-£6£32£6
Forex Effect-£0£0-£0-£0
Net Chg. in Cash£0£0£30£0
Supplemental Information
Beg. Cash£0£30£0£0
End Cash£0£9,503£30£0
Free Cash Flow-£5-£14-£9-£11